Why the study?
Does bromocriptine mesylate improve outcomes in patients with Neuroleptic Malignant Syndrome?
Population
2 patients with Neuroleptic Malignant Syndrome (NMS)
Comparison
Bromocriptine mesylate vs Usual care
Design
Case_report
Authors
Loading...
Does not support changing NMS management; single case leaves bromocriptine efficacy open for prospective trials.
Does bromocriptine mesylate improve outcomes in patients with Neuroleptic Malignant Syndrome?
This case report describes the first successful use of bromocriptine mesylate for the treatment of Neuroleptic Malignant Syndrome.
Peter S. Mueller (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: